This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

GTCR-Surmodics' divestiture buyer Integer failed at business in past, US FTC says

( August 22, 2025, 12:26 GMT | Official Statement) -- MLex Summary: The US Federal Trade Commission sad GTCR and Surmodics plan to divest a portion of the Biocoat business to Integer, a contract development and manufacturing organization that provides its services to medical device companies, won’t resolve the competitive harms in the market for outsourced hydrophilic coatings. In a reply brief in support of its motion for a preliminary injunction, the government says Integer does not have a hydrophilic coating production business today and has failed in its attempts to build this business in the past.See file attachment. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login